Comparative Transcriptomics of Canine and Human Natural Killer Cells as Immunotherapy Target in Translational Osteosarcoma Model.

被引：0
|
作者：
Gingrich, A. A. [1 ]
Judge, S.
Reiter, T. [2 ]
York, D. [2 ]
Yanagisawa, M. [1 ]
Sturgill, I. [2 ]
Basmaci, U. [2 ]
Brady, R. [2 ]
Stoffel, K. [2 ]
Brown, C. [2 ]
Rebhun, R. [2 ]
Canter, R. J. [1 ]
机构：
[1] Univ Calif Davis, Surg, Davis Canc Ctr, Sacramento, CA 95817 USA
[2] Univ Calif Davis, Sacramento, CA 95817 USA
来源：
ANNALS OF SURGICAL ONCOLOGY | 2020年 / 27卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P241
引用
收藏
页码：S139 / S140
页数：2
相关论文
共 50 条
  • [41] Effect of IL-18 on the Expansion and Phenotype of Human Natural Killer Cells: Application to Cancer Immunotherapy
    Senju, Hiroaki
    Kumagai, Asuka
    Nakamura, Yoichi
    Yamaguchi, Hiroyuki
    Nakatomi, Katsumi
    Fukami, Shota
    Shiraishi, Kengo
    Harada, Yuka
    Nakamura, Mitsuhiro
    Okamura, Haruki
    Tanaka, Yoshimasa
    Mukae, Hiroshi
    INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2018, 14 (03): : 331 - 340
  • [42] Characterization and ex vivo expansion of human placenta-derived natural killer cells for cancer immunotherapy
    Kang, Lin
    Voskinarian-Berse, Vanessa
    Law, Eric
    Reddin, Tiffany
    Bhatia, Mohit
    Hariri, Alexandra
    Ning, Yuhong
    Dong, David
    Maguire, Timothy
    Yarmush, Martin
    Hofgartner, Wolfgang
    Abbot, Stewart
    Zhang, Xiaokui
    Hariri, Robert
    FRONTIERS IN IMMUNOLOGY, 2013, 4
  • [43] Target-induced death by apoptosis in human lymphokine-activated natural killer cells
    Taga, K
    Yamauchi, A
    Kabashima, K
    Bloom, ET
    Muller, J
    Tosato, G
    BLOOD, 1996, 87 (06) : 2411 - 2418
  • [44] TRIPLE-DRUG ORAL IMMUNOTHERAPY TARGETING MYELOID CELLS FOR TREATMENT OF METASTATIC OSTEOSARCOMA EVALUATED IN SPONTANEOUS CANINE MODEL
    London, Cheryl
    Regan, Dan
    Chow, Lyndah
    Weishaar, Kristen
    Gardner, Heather
    Thamm, Doug
    Dow, Steven
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A877 - A877
  • [45] CELL-SURFACE GLYCOCONJUGATES AS POSSIBLE TARGET STRUCTURES FOR HUMAN NATURAL-KILLER-CELLS
    VOSHOL, H
    DULLENS, HFJ
    DENOTTER, W
    VLIEGENTHART, JFG
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1993, : 374 - 374
  • [46] GANGLIOSIDE GM2 AS A TARGET STRUCTURE RECOGNIZED BY HUMAN NATURAL-KILLER-CELLS
    ANDO, I
    HOON, DB
    PATTENGALE, PK
    GOLUB, SH
    IRIE, RF
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 1987, 1 (02) : 209 - 213
  • [47] Magnetically labeled human natural killer cells, accumulated in vitro by an external magnetic force, are effective against HOS osteosarcoma cells
    Nakashima, Y
    Deie, M
    Yanada, S
    Sharman, P
    Ochi, M
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2005, 27 (04) : 965 - 971
  • [48] SPECIFIC MEMBRANE GLYCOPEPTIDES FROM THE HUMAN NATURAL-KILLER SUSCEPTIBLE TARGET, K562, INHIBIT CYTOLYSIS OF NATURAL-KILLER CELLS
    ADES, EW
    HINSON, A
    DECKER, J
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1983, 24 (MAR): : 228 - 228
  • [49] Interleukin-12 induces efficient lysis of natural killer-sensitive and natural killer-resistant human osteosarcoma cells: The synergistic effect of interleukin-2
    Mariani, E
    Meneghetti, A
    Tarozzi, A
    Cattini, L
    Facchini, A
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2000, 51 (06) : 618 - 625
  • [50] Activated and expanded natural killer cells target osteosarcoma tumor initiating cells in an NKG2D-NKG2DL dependent manner
    Fernandez, L.
    Valentin, J.
    Zalacain, M.
    Leung, W.
    Patino-Garcia, A.
    Perez-Martinez, A.
    CANCER LETTERS, 2015, 368 (01) : 54 - 63
12345